Medtronic plc financials

  1. Home
  2. Financials
  3. MDT
MDT CIK 0001613103

Source: EDGAR filings · Built 2026-06-02T03:32:06Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 5.18B 5.20B 4.58B 5.98B 4.88B 6.02B
EBITDA 8.82B 7.79B 8.18B 8.46B 7.19B 7.45B
Working Capital 10.94B 11.15B 12.62B 10.66B 14.04B 11.66B
Net Debt 24.53B 24.75B 23.85B 17.53B 23.80B 21.77B
Gross Margin 65.32% 65.34% 65.67% 67.98% 65.19% 12.91%
Operating Margin 17.76% 15.89% 17.56% 18.15% 14.89% 16.57%
Net Margin 13.90% 11.36% 12.03% 15.90% 11.97% 16.56%
Return on Equity (ROE) 9.71% 7.32% 7.30% 9.59% 7.01% 9.44%
Return on Assets (ROA) 5.09% 4.09% 4.13% 5.54% 3.87% 5.28%
Current Ratio 1.85× 2.03× 2.39× 1.86× 2.65× 2.13×
Debt-to-Equity 0.56× 0.52× 0.49× 0.40× 0.53× 0.51×
Effective Tax Rate 16.63% 23.42% 29.46% 8.27% 6.80% -18.52%
Cash Conversion Ratio 1.51× 1.85× 1.61× 1.46× 1.73× 1.51×
Accruals Ratio -0.03× -0.03× -0.03× -0.03× -0.03× -0.03×
SBC % of Revenue 1.28% 1.21% 1.14% 1.13% 1.14% 1.03%
CapEx Coverage 3.79× 4.28× 4.14× 5.37× 4.61× 5.96×
Free Cash Flow Per Share $4.02 $3.91 $3.44 $4.42 $3.61 $4.46

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 23.31× 28.89× 32.25× 27.98× 49.22× 28.05×
P/FCF 20.94× 20.40× 26.47× 23.59× 36.29× 22.28×
FCF Yield 4.78% 4.90% 3.78% 4.24% 2.76% 4.49%
EV / EBITDA 15.02× 16.60× 17.71× 18.49× 27.82× 20.79×
P/S 3.22× 3.23× 3.88× 4.38× 5.85× 4.61×
P/B 2.25× 2.08× 2.35× 2.64× 3.42× 2.62×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 33.54B 32.36B 31.23B 31.69B 30.12B 28.91B
Cost of Goods and Services Sold 11.63B 11.22B 10.72B 10.14B 10.48B 9.42B
Gross Profit — — — — — 3.73B
Selling, General and Administrative Expense 10.85B 10.74B 10.41B 10.29B 10.15B 10.11B
Operating Income (Loss) 5.96B 5.14B 5.49B 5.75B 4.48B 4.79B
Income Tax Expense (Benefit) 936.00M 1.13B 1.58B 456.00M 265.00M -751.00M
Net Income (Loss) Attributable to Parent 4.66B 3.68B 3.76B 5.04B 3.61B 4.79B
Earnings Per Share, Basic $3.63 $2.77 $2.83 $3.75 $2.68 $3.57
Weighted Average Number of Shares Outstanding, Basic 1.29B 1.33B 1.33B 1.34B 1.34B 1.34B
Earnings Per Share, Diluted $3.61 $2.76 $2.82 $3.73 $2.66 $3.54
Weighted Average Number of Shares Outstanding, Diluted 1.29B 1.33B 1.33B 1.35B 1.35B 1.35B

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 2.22B 1.28B 1.54B 3.71B 3.59B 4.14B
Assets, Current 23.81B 21.93B 21.68B 23.06B 22.55B 22.03B
Assets 91.68B 89.98B 90.95B 90.98B 93.08B 90.69B
Liabilities, Current 12.88B 10.79B 9.05B 12.39B 8.51B 10.37B
Long-term Debt, Excluding Current Maturities — — — — — 22.14B
Liabilities 43.42B 39.56B 39.28B 38.26B 41.48B 39.82B
Stockholders' Equity Attributable to Parent 48.02B 50.21B 51.48B 52.55B 51.43B 50.74B
Common Stock, Shares, Outstanding 1.28B 1.31B 1.33B 1.33B 1.35B 1.34B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 7.04B 6.79B 6.04B 7.35B 6.24B 7.23B
Payments to Acquire Property, Plant, and Equipment 1.86B 1.59B 1.46B 1.37B 1.35B 1.21B
Net Cash Provided by (Used in) Investing Activities -1.94B -2.37B -3.49B -1.66B -2.87B -3.20B
Payments for Repurchase of Common Stock 3.23B 2.14B 645.00M 2.54B 652.00M 1.33B
Net Cash Provided by (Used in) Financing Activities -4.36B -4.45B -4.96B -5.34B -4.14B -4.20B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MDT CIK 0001613103), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

AXS

AXIS CAPITAL HOLDINGS LIMITED

HSY

HERSHEY CO

RMBS

RAMBUS INC